Sfoglia per AUTORE
KUMAR S
Collezione AOU Città della Salute di Torino

  

Items : 14

Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2025 Feb 12:JCO2402020. doi: 10.1200/JCO-24-02020.
2025
AOU Città della Salute di Torino

Shi Q; Paiva B; Pederson LD; Dimier N; Talpes E; Prior TJ; Orfao A; Moreau P; Sonneveld P; Kumar SK; Dixon JG; Patel R; Bartlett BJ; Schecter J; McCarthy P; Hose D; Seckinger A; Mattia D; Goldschmidt H; Oliva S; Owen RG; Anderson KC; San-Miguel J; Durie BGM; Munshi N;

Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging Strategies. in American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting / Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e433520. doi: 10.1200/EDBK_433520.
2024
AOU Città della Salute di Torino

Rees MJ; D'Agostino M; Leypoldt LB; Kumar S; Weisel KC; Gay F;

ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Jun;28(6):284-293. doi: 10.1016/j.jtct.2022.03.019. Epub 2022 Mar 17.
2022
AOU Città della Salute di Torino

Silberman R; Iftikhar R; Abonour R; Moreau P; Otero PR; Malhotra P; Biran N; Callander N; Janakiram M; Mohty M; Prince M; Beksac M; Chaudhry M; Aljurf M; Costa L; Hou J; Schriber J; Quach H; Einsele H; Cook G; Gay F; Costello C; Poudyal BS; Cowan A; Garfall A; Lonial S; Kumar A; Shah N; Kansagra A; et alii...

Multiple myeloma with t(11;14): unique biology and evolving landscape. in American journal of cancer research / Am J Cancer Res. 2022 Jul 15;12(7):2950-2965. eCollection 2022.
2022
AOU Città della Salute di Torino

Costa LJ; Dogan A; Hungria VT; Gay F; Fonseca R; Kumar SK; Bal S;

Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2021 Oct 1;27(19):5195-5212. doi: 10.1158/1078-0432.CCR-21-1059.
2021
AOU Città della Salute di Torino

Anderson KC; Auclair D; Adam SJ; Agarwal A; Anderson M; Avet-Loiseau H; Bustoros M; Chapman J; Connors DE; Dash A; Di Bacco A; Du L; Facon T; Flores-Montero J; Gay F; Ghobrial IM; Gormley NJ; Gupta I; Higley H; Hillengass J; Kanapuru B; Kazandjian D; Kelloff GJ; Kirsch IR; Kremer B; Landgren O; Lightbody E; Lomas OC; Lonial S; et alii...

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. in The Lancet. Oncology / Lancet Oncol. 2021 Mar;22(3):e105-e118. doi: 10.1016/S1470-2045(20)30756-7.
2021
AOU Città della Salute di Torino

Moreau P; Kumar SK; San Miguel J; Davies F; Zamagni E; Bahlis N; Ludwig H; Mikhael J; Terpos E; Schjesvold F; Martin T; Yong K; Durie BGM; Facon T; Jurczyszyn A; Sidana S; Raje N; van de Donk N; Lonial S; Cavo M; Kristinsson SY; Lentzsch S; Hajek R; Anderson KC; João C; Einsele H; Sonneveld P; Engelhardt M; Fonseca R; et alii...

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma. in Blood advances / Blood Adv. 2020 Nov 10;4(21):5449-5459. doi: 10.1182/bloodadvances.2020001965.
2020
AOU Città della Salute di Torino

Facon T; Niesvizky R; Mateos MV; Siegel D; Rosenbaum C; Bringhen S; Weisel K; Ho PJ; Ludwig H; Kumar S; Wang K; Obreja M; Yang Z; Klippel Z; Mezzi K; Goldrick A; Tekle C; Dimopoulos MA;

2020
AOU Città della Salute di Torino

Chari A; Samur MK; Martinez-Lopez J; Cook G; Biran N; Yong K; Hungria V; Engelhardt M; Gay F; García Feria A; Oliva S; Oostvogels R; Gozzetti A; Rosenbaum C; Kumar S; Stadtmauer EA; Einsele H; Beksac M; Weisel K; Anderson KC; Mateos MV; Moreau P; San-Miguel J; Munshi NC; Avet-Loiseau H;

The stepchild in myeloma treatments: is allogeneic transplantation not so bad after all? in Haematologica / Haematologica. 2019 Feb;104(2):222-225. doi: 10.3324/haematol.2018.206987.
2019
AOU Città della Salute di Torino

Müller AMS; Kumar SK; Bruno B;

Multiple myeloma. in Nature reviews. Disease primers / Nat Rev Dis Primers. 2017 Jul 20;3:17046. doi: 10.1038/nrdp.2017.46.
2017
AOU Città della Salute di Torino

Kumar SK; Rajkumar V; Kyle RA; van Duin M; Sonneveld P; Mateos MV; Gay F; Anderson KC;

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. in The Lancet. Oncology / Lancet Oncol. 2016 Aug;17(8):e328-e346. doi: 10.1016/S1470-2045(16)30206-6.
2016
AOU Città della Salute di Torino

Kumar S; Paiva B; Anderson KC; Durie B; Landgren O; Moreau P; Munshi N; Lonial S; Bladé J; Mateos MV; Dimopoulos M; Kastritis E; Boccadoro M; Orlowski R; Goldschmidt H; Spencer A; Hou J; Chng WJ; Usmani SZ; Zamagni E; Shimizu K; Jagannath S; Johnsen HE; Terpos E; Reiman A; Kyle RA; Sonneveld P; Richardson PG; McCarthy P; et alii...

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. in Blood / Blood. 2015 Mar 26;125(13):2068-74. doi: 10.1182/blood-2014-12-615187. Epub 2015 Jan 27.
2015
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Mateos MV; Larocca A; Facon T; Kumar SK; Offidani M; McCarthy P; Evangelista A; Lonial S; Zweegman S; Musto P; Terpos E; Belch A; Hajek R; Ludwig H; Stewart AK; Moreau P; Anderson K; Einsele H; Durie BG; Dimopoulos MA; Landgren O; San Miguel JF; Richardson P; Sonneveld P; Rajkumar SV;

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. in The Lancet. Oncology / Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.
2014
AOU Città della Salute di Torino

Rajkumar SV; Dimopoulos MA; Palumbo A; Blade J; Merlini G; Mateos MV; Kumar S; Hillengass J; Kastritis E; Richardson P; Landgren O; Paiva B; Dispenzieri A; Weiss B; LeLeu X; Zweegman S; Lonial S; Rosinol L; Zamagni E; Jagannath S; Sezer O; Kristinsson SY; Caers J; Usmani SZ; Lahuerta JJ; Johnsen HE; Beksac M; Cavo M; Goldschmidt H; et alii...

Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data. in The Lancet. Oncology / Lancet Oncol. 2014 Mar;15(3):333-42. doi: 10.1016/S1470-2045(13)70609-0. Epub 2014 Feb 11.
2014
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Kumar SK; Lupparelli G; Usmani S; Waage A; Larocca A; van der Holt B; Musto P; Offidani M; Petrucci MT; Evangelista A; Zweegman S; Nooka AK; Spencer A; Dimopoulos MA; Hajek R; Cavo M; Richardson P; Lonial S; Ciccone G; Boccadoro M; Anderson K; Barlogie B; Sonneveld P; McCarthy PL;